04/12/2024
5:52 PM | Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/11/2024
7:01 AM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:10 AM | Eliem Therapeutics (Filer)
| Form DEFA14A | |
04/08/2024
4:33 PM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:05 PM | Eliem Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
3:33 PM | Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
10:07 AM | Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
10:53 AM | BML Investment Partners, L.P. (Filed by)
Eliem Therapeutics (Subject)
| Form SC 13G/A | |
11/17/2023
3:30 PM | Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
11/14/2023
3:01 PM | Eliem Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
4:13 PM | AI ETI LLC (Filed by)
Eliem Therapeutics (Subject)
| Form SC 13D/A | |
07/20/2023
5:55 AM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
4:08 PM | Dunn Judith (Reporting)
Eliem Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:11 PM | Eliem Therapeutics (Issuer)
Ratcliffe Liam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:13 PM | Eliem Therapeutics (Issuer)
Tate Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:22 PM | Eliem Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:45 PM | Eliem Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
